Adverse reactions to rifampicin in antituberculosis regimens
about
Acute hemolysis and renal failure following discontinuous use of rifampinFlu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak.Tuberculosis: 9. Treatment.Adverse reactions to first-line antituberculosis drugs.Hypersensitivity reactions to non beta-lactam antimicrobial agents, a statement of the WAO special committee on drug allergy.Current development and future prospects in chemotherapy of tuberculosisComparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment.Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.Adverse reactions to rifampicin.Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial.Mechanism Investigation of Rifampicin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice.[Adverse effects of rifampicin]Rifampicin-induced upper gastrointestinal bleeding.Rifampicin in non-tuberculous infections.Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia.Clinical features of Mycobacterium ulcerans infection.Rifampicin for lepromatous leprosy: nine years' experience.Toxicity associated with tuberculosis chemotherapy in the REMoxTB studyLack of association between rifampicin plasma concentration and treatment-related side effects in osteoarticular infections
P2860
Q28333942-893C53E7-7BFF-407D-B3B5-69692C6B9E56Q33165650-AC4DEF6A-8055-44F0-961D-0459829F41CAQ33396678-60FB799C-FBA7-499E-B388-E962D19D2ABFQ33729210-2D42AB93-610D-4A4E-9F9B-97D015B085AFQ34497890-B24841BC-39FD-4A66-AA9B-A80E1D3918F8Q35657599-5DA1C08A-E72B-4250-A28C-ABCEDC1C1BB6Q35705874-E6D27AAE-C75A-42DC-A9C9-A91648ABE5F3Q35714933-FC0D061E-E593-4186-B960-253842B1DB1EQ36115081-988656FD-B337-4390-AA31-5382F629DD28Q36674793-2E24AC1A-B36F-4D70-8310-4027B620A00CQ36998032-6337F274-AE91-4E28-BA4A-4B6DF174DD3FQ37178168-8FAEE4EF-A339-42F0-B3F1-0C3F5EF6B1ACQ38431738-A577365D-9BBD-4839-B811-EB8BDD873DB1Q38616064-278EFA77-3DF6-495C-8D83-B729D33556B3Q39201462-26448B24-DB6E-4FC0-BA73-7863E2F422EEQ43050782-D81DB66D-7065-4016-93BA-E86576B9B4AAQ52957929-DF82A7EC-A073-4CCF-ABB7-1890914F6BA8Q54008049-C92C4805-67D2-471C-97D6-ABE8D787E6E1Q54588403-05211765-082B-44D3-931E-3E53ED709C58Q56969466-12AD3106-C0A2-4CD5-A9A0-5E87FB2404C2Q58856447-23759C8F-CEA8-4371-A856-B6836F5A82DD
P2860
Adverse reactions to rifampicin in antituberculosis regimens
description
1977 nî lūn-bûn
@nan
1977 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի մարտին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Adverse reactions to rifampicin in antituberculosis regimens
@ast
Adverse reactions to rifampicin in antituberculosis regimens
@en
Adverse reactions to rifampicin in antituberculosis regimens
@nl
type
label
Adverse reactions to rifampicin in antituberculosis regimens
@ast
Adverse reactions to rifampicin in antituberculosis regimens
@en
Adverse reactions to rifampicin in antituberculosis regimens
@nl
prefLabel
Adverse reactions to rifampicin in antituberculosis regimens
@ast
Adverse reactions to rifampicin in antituberculosis regimens
@en
Adverse reactions to rifampicin in antituberculosis regimens
@nl
P3181
P356
P1476
Adverse reactions to rifampicin in antituberculosis regimens
@en
P2093
D J Girling
P304
P3181
P356
10.1093/JAC/3.2.115
P407
P577
1977-03-01T00:00:00Z